Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China  

作　　者：Yunfan Yang Yanli Zhang Qian Jiang Li Meng Weiming Li Bingcheng Liu Xiaoli Liu Li Zhou Rong Liang Xiaojian Zhu Na Xu Pu Kuang Ting Lin Huanling Zhu 

机构地区：[1]Department of Hematology,Institute of Hematology,West China Hospital of Sichuan University,Chengdu,Sichuan 610041,China [2]Department of Hematology,Affiliated Cancer Hospital of Zhengzhou University,Henan Provincial Tumor Hospital,Zhengzhou,Henan 450000,China [3]Department of Hematology,Peking University People’s Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100000,China [4]Department of Hematology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430000,China [5]Department of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430000,China [6]Department of Leukemia,National Clinical Research Center for Blood Disease,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences,Tianjin 300020,China [7]Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong 510000,China [8]Department of Leukemia,Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 201100,China [9]Department of Hematology,Xijing Hospital,Air Force Medical University of PLA,Xi’an,Shaanxi 710000,China

出　　处：《Chinese Medical Journal》2022年第12期1498-1499,共2页中华医学杂志（英文版）

摘　　要：To the Editor:As of July 4,2021,the severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)pandemic has affected>0.18 billion individuals and caused>3.9milliondeaths worldwide.ll Currently,the only method to radically overcome this pandemic is extensive vaccination.However,the clinical trials assessing most vaccines against SARS-CoV-2 have excluded patients with hematological tumors.

关 键 词：vaccines PATIENTS ACUTE 

分 类 号：R733.72[医药卫生—肿瘤] R186[医药卫生—临床医学]